PDF(Pubmed)
Abstract：
The clinical research pipeline is critical to ensuring continued development of novel treatments that can offer patients with cancer safe and effective options. Unfortunately, progress has slowed since the COVID-19 pandemic due to uncovered, systemic inefficiencies across critical processes. Towards initiating discussion on how to reinvigorate clinical research, the Society for Immunotherapy of Cancer (SITC) hosted a virtual summit that characterized issues and formed potential solutions. This commentary serves to highlight the crisis facing clinical research as well as stimulate field-wide discussion on how to better serve patients into the future.
摘要：
临床研究管道对于确保可为癌症患者提供安全有效选择的新型治疗方法的持续发展至关重要。不幸的是,自COVID-19大流行以来，进展已经放缓，跨关键流程的系统性低效率。开始讨论如何振兴临床研究，癌症免疫治疗协会（SITC）主办了一次虚拟峰会，该峰会表征了问题并形成了潜在的解决方案。这篇评论强调了临床研究面临的危机，并激发了关于如何更好地为患者提供未来服务的广泛讨论。
